What are the treatment options for a patient with invasive carcinoma of the breast, estrogen receptor (ER) positive, progesterone receptor (PgR) negative, and human epidermal growth factor receptor 2 (HER2) negative, with lymph node involvement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 1, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the recommended adjuvant treatment plan for a patient with invasive ductal carcinoma stage II (ypT0N0M0), estrogen receptor positive (ER+), progesterone receptor positive (PR+), and human epidermal growth factor receptor 2 positive (HER2+)?

What is the recommended treatment plan for a patient with infiltrating mammary carcinoma, grade 3, and high-grade ductal carcinoma in situ, with negative lymph nodes?

What is the recommended adjuvant chemotherapy regimen, follow-up schedule, and surveillance monitoring for a patient with Invasive Ductal Carcinoma (IDC), Stage IIA, Estrogen Receptor positive (ER+), Progesterone Receptor positive (PR+), and Human Epidermal growth factor Receptor 2 (HER2) equivocal Fluorescence In Situ Hybridization (FISH+) positive, status post (S/P) core needle biopsy (CNB) and neoadjuvant chemotherapy?

What is the best neoadjuvant and adjuvant therapy for a 66-year-old post-menopausal female with cT2N0M0 (clinical stage 2, no lymph node involvement, no distant metastasis) right breast invasive ductal carcinoma, estrogen receptor (ER) 80% positive, progesterone receptor (PR) 30% positive, and human epidermal growth factor receptor 2 (HER2) 3+ positive (triple positive)?

What is the treatment plan for a patient with invasive breast carcinoma, estrogen receptor (ER) positive, progesterone receptor (PR) positive, and human epidermal growth factor receptor 2 (HER2) negative, with a Ki-67 index indicating low proliferation?

How to manage hypotension?

What is the origin of Craniopharyngioma vs Teratoma and which tumor typically contains mesenchymal components?

Can cortisone injections be administered to a knee with a total knee replacement (TKR)?

What are examples of aminoglycosides?

What are the criteria for diagnosing acute decompensation of heart failure?

What is the treatment for hypokalemia (low potassium levels)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.